EP Patent

EP0377477A1 — Process for microencapsulation

Assigned to BROCADES-PHARMA BV · Expires 1990-07-11 · 36y expired

What this patent protects

A process for microencapsulating bioactive substances in bio­compatible polymers according to the phase-separation prin­ciple, wherein an excess of an ethyl or isopropyl ester of a straight-chain fatty acid having 12-18 carbon atoms is used as the hardening liquid, and the pharma…

USPTO Abstract

A process for microencapsulating bioactive substances in bio­compatible polymers according to the phase-separation prin­ciple, wherein an excess of an ethyl or isopropyl ester of a straight-chain fatty acid having 12-18 carbon atoms is used as the hardening liquid, and the pharmaceutical compositions containing the microcapsules prepared by this process. Iso­propyl myristate and isopropyl palmitate are preferred hardening liquids.

Drugs covered by this patent

Patent Metadata

Patent number
EP0377477A1
Jurisdiction
EP
Classification
—
Expires
1990-07-11
Drug substance claim
No
Drug product claim
No
Assignee
BROCADES-PHARMA BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.